Genome shuffling in the ethanologenic yeast Candida krusei to improve acetic acid tolerance

Biotechnology and Applied Biochemistry
Pingying WeiNing Jiang

Abstract

Genome shuffling was used to improve the acetic acid tolerance of an ethanologenic yeast, Candida krusei GL560. A mutant, S4-3, was isolated and selected after four rounds of genome shuffling. It was found that the mutant S4-3 had a higher viability in the YNBX (yeast nitrogen base/xylose) medium with acetic acid and grew better in the YPD (yeast extract, peptone and dextrose) medium [1% (w/v) yeast extract, 2% (w/v) peptone and 2% (w/v) glucose] with acetic acid than the parent strain GL560. The mutant S4-3 also improved its multiple stress tolerance to ethanol, H2O2, heat and freeze-thaw. Furthermore, S4-3 showed higher ethanol production than GL560 in EFM (ethanol fermentation medium) with or without acetic acid. The DNA content of S4-3 was similar to its parent strains in the genome shuffling. This suggested that gene exchange, as caused by homologous recombination, may have occurred during the process. Higher membrane integrity and intracellular catalase activity were two possible reasons for the higher acid-tolerance phenotype of S4-3. These results indicated that genome shuffling is a powerful means of rapidly improving the complex traits of non-haploid organisms, while still maintaining robust growth.

Citations

Jul 24, 2010·Journal of Industrial Microbiology & Biotechnology·Dao-Qiong ZhengYu-Hua Zhao
Jan 21, 2009·Biotechnology Letters·Lihua Hou
Jul 19, 2012·World Journal of Microbiology & Biotechnology·Xiaohong CaoLihua Hou
Feb 14, 2009·Applied Biochemistry and Biotechnology·Lihua Hou
Mar 3, 2009·Applied and Environmental Microbiology·Derek A AbbottAntonius J A van Maris
Mar 7, 2014·Applied Microbiology and Biotechnology·Damien Biot-Pelletier, Vincent J J Martin
Mar 20, 2010·Journal of Microbiological Methods·Paramjit K BajwaHung Lee
May 26, 2009·Biotechnology Advances·Jixian GongXueming Zhao
Jun 16, 2011·Journal of Applied Microbiology·N ClermontC Beaulieu
Aug 10, 2013·Biotechnology and Bioengineering·Christopher Leber, Nancy A Da Silva
Apr 15, 2014·FEMS Microbiology Reviews·Jan SteenselsKevin J Verstrepen
Feb 18, 2011·Bioengineered Bugs·Jose-Luis Adrio, Arnold L Demain
Jan 24, 2014·Journal of Biotechnology·Souvik BasakRongrong Jiang
Nov 19, 2014·Journal of Industrial Microbiology & Biotechnology·Nicole K HarnerHung Lee
Jul 29, 2008·Metabolic Engineering·Curt R FischerGregory Stephanopoulos
Jan 13, 2018·Frontiers in Bioengineering and Biotechnology·Kentaro InokumaAkihiko Kondo
Nov 21, 2017·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Nuttaporn ChamnipaPornthap Thanonkeo
Apr 1, 2010·Journal of the Science of Food and Agriculture·Xiaohong CaoBin Zeng
Feb 21, 2020·International Journal of Molecular Sciences·Soujanya Lakshmi EgaSudhamani Muddada
Aug 11, 2016·Biotechnology and Applied Biochemistry·Ping YuPeng Li
Oct 16, 2018·Food Science and Biotechnology·Monika Kordowska-WiaterKrzysztof Kostro
Sep 25, 2020·World Journal of Microbiology & Biotechnology·Liang ChenKe Bian

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.